This indicates that LRH-1 functions in breast cancer cells not only by mediating oestrogen action at non-ERα target genes following stimulation of its expression by ERα (which may be viewed as a classic mechanism by which a signal transduction pathway response may be amplified) but also by potentiating ERα action at many genes that are direct targets of ERα. This evidence concerns the gene ESR1 and breast carcinoma.